Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 333

1.

Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey.

Yerly S, von Wyl V, Ledergerber B, Böni J, Schüpbach J, Bürgisser P, Klimkait T, Rickenbach M, Kaiser L, Günthard HF, Perrin L; Swiss HIV Cohort Study.

AIDS. 2007 Oct 18;21(16):2223-9.

PMID:
18090050
[PubMed - indexed for MEDLINE]
2.

The prevalence of resistance-associated mutations to protease and reverse transcriptase inhibitors in treatment-naïve (HIV1)-infected individuals in Casablanca, Morocco.

Bakhouch K, Oulad-Lahcen A, Bensghir R, Blaghen M, Elfilali KM, Ezzikouri S, Abidi O, Hassar M, Wakrim L.

J Infect Dev Ctries. 2009 Jun 1;3(5):380-91.

PMID:
19759509
[PubMed - indexed for MEDLINE]
Free Article
3.

Stable prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in France.

Chaix ML, Descamps D, Harzic M, Schneider V, Deveau C, Tamalet C, Pellegrin I, Izopet J, Ruffault A, Masquelier B, Meyer L, Rouzioux C, Brun-Vezinet F, Costagliola D.

AIDS. 2003 Dec 5;17(18):2635-43.

PMID:
14685058
[PubMed - indexed for MEDLINE]
4.

Transmission of drug-resistant HIV-1 in Europe remains limited to single classes.

SPREAD programme.

AIDS. 2008 Mar 12;22(5):625-35. doi: 10.1097/QAD.0b013e3282f5e062.

PMID:
18317004
[PubMed - indexed for MEDLINE]
5.

[Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].

Oette M, Kaiser R, Däumer M, Fätkenheuer G, Rockstroh JK, Knechten H, Mitrenga D, Beerenwinkel N, Sagir A, Pfister H, Häussinger D.

Dtsch Med Wochenschr. 2007 May 4;132(18):977-82. German.

PMID:
17457780
[PubMed - indexed for MEDLINE]
6.

A population-based approach to determine the prevalence of transmitted drug-resistant HIV among recent versus established HIV infections: results from the Canadian HIV strain and drug resistance surveillance program.

Jayaraman GC, Archibald CP, Kim J, Rekart ML, Singh AE, Harmen S, Wood M, Sandstrom P.

J Acquir Immune Defic Syndr. 2006 May;42(1):86-90.

PMID:
16763495
[PubMed - indexed for MEDLINE]
7.

Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment-naive patients: implications for routine resistance screening before initiation of antiretroviral therapy.

Novak RM, Chen L, MacArthur RD, Baxter JD, Huppler Hullsiek K, Peng G, Xiang Y, Henely C, Schmetter B, Uy J, van den Berg-Wolf M, Kozal M; Terry Beirn Community Programs for Clinical Research on AIDS 058 Study Team.

Clin Infect Dis. 2005 Feb 1;40(3):468-74. Epub 2005 Jan 10.

PMID:
15668873
[PubMed - indexed for MEDLINE]
Free Article
8.

Genotypic resistance of antiretroviral drugs among drug-naive HIV type 1 patients with the background of long-term access-easy zidovudine therapy.

Park SW, Kim HB, Choi YJ, Kim NJ, Oh MD, Choe KW.

AIDS Res Hum Retroviruses. 2003 Nov;19(11):1039-43.

PMID:
14686324
[PubMed - indexed for MEDLINE]
9.

Prevalence of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy: evolution over 12 years and predictors.

Bracciale L, Colafigli M, Zazzi M, Corsi P, Meraviglia P, Micheli V, Maserati R, Gianotti N, Penco G, Setti M, Di Giambenedetto S, Butini L, Vivarelli A, Trezzi M, De Luca A.

J Antimicrob Chemother. 2009 Sep;64(3):607-15. doi: 10.1093/jac/dkp246. Epub 2009 Jul 16.

PMID:
19608581
[PubMed - indexed for MEDLINE]
Free Article
10.

Trends in antiretroviral drug resistance and clade distributions among HIV-1--infected blood donors in Sao Paulo, Brazil.

Barreto CC, Nishyia A, Araújo LV, Ferreira JE, Busch MP, Sabino EC.

J Acquir Immune Defic Syndr. 2006 Mar;41(3):338-41.

PMID:
16540943
[PubMed - indexed for MEDLINE]
11.

Drug resistant mutations detected by genotypic drug resistance testing in patients failing therapy in clade C HIV-1 infected individuals from India.

Kandathil AJ, Kannangai R, Verghese VP, Pulimood SA, Rupali P, Sridharan G, Grant P, Pillay D, Abraham OC.

Indian J Med Microbiol. 2009 Jul-Sep;27(3):231-6. doi: 10.4103/0255-0857.53205.

PMID:
19584504
[PubMed - indexed for MEDLINE]
Free Article
12.

Molecular epidemiology and prevalence of drug resistance-associated mutations in newly diagnosed HIV-1 patients in Portugal.

Palma AC, Araújo F, Duque V, Borges F, Paixão MT, Camacho R; Portuguese SPREAD Network.

Infect Genet Evol. 2007 Jun;7(3):391-8. Epub 2007 Feb 8.

PMID:
17360244
[PubMed - indexed for MEDLINE]
13.

Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain.

de Mulder M, Yebra G, Martín L, Prieto L, Mellado MJ, Rojo P, Muñoz-Fernández MÁ, Jiménez de Ory S, Ramos JT, Holguín A; Madrid cohort of HIV-infected children.

J Antimicrob Chemother. 2011 Oct;66(10):2362-71. doi: 10.1093/jac/dkr305. Epub 2011 Aug 2.

PMID:
21810838
[PubMed - indexed for MEDLINE]
Free Article
14.

Prevalence and risk factors associated with antiretroviral resistance in HIV-1-infected children.

Delaugerre C, Warszawski J, Chaix ML, Veber F, Macassa E, Buseyne F, Rouzioux C, Blanche S.

J Med Virol. 2007 Sep;79(9):1261-9.

PMID:
17607781
[PubMed - indexed for MEDLINE]
15.

[Prevalence of drug resistance mutations among antiretroviral drug-naive HIV-1-infected patients in China].

Si XF, Huang HL, Wei M, Guan Q, Song YH, Ma PF, Quan Y, Xing H, Shao YM.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2004 Dec;18(4):308-11. Chinese.

PMID:
15650776
[PubMed - indexed for MEDLINE]
16.

Prevalence of primary HIV drug resistance among seroconverters during an explosive outbreak of HIV infection among injecting drug users.

Alexander CS, Dong W, Schechter MT, O'Shaughnessy MV, Strathdee SA, Mo T, Montaner JS, Harrigan PR.

AIDS. 1999 May 28;13(8):981-5.

PMID:
10371180
[PubMed - indexed for MEDLINE]
17.

Prevalence of HIV-1 drug resistance mutations among Spanish prison inmates.

García-Guerrero J, Sáiz de la Hoya P, Portilla J, Marco A, Sánchez-Payá J, Moreno S; Estudio de Resistencias en Prisiones Group.

Eur J Clin Microbiol Infect Dis. 2006 Nov;25(11):695-701.

PMID:
17043836
[PubMed - indexed for MEDLINE]
18.

Prevalence of transmitted antiretroviral resistance and distribution of HIV-1 subtypes among patients with recent infection in Catalonia (Spain) between 2003 and 2005.

Romero A, Sued O, Puig T, Esteve A, Pumarola T, Casabona J, González V, Matas L, Tural C, Rodrigo I, Margall N, Domingo P, Casanova A, Ferrer E, Caballero E, Ribera E, Farré J, Puig T, Amengual MJ, Navarro G, Prat JM, Masabeu A, Simó JM, Villaverde CA, Barrufet P, Sauca MG, Ortin X, Ortí A, Navarro R, Euras JM, Vilaró J, Villà MC, Montull S, Vilanova C, Pujol F, Díaz O, Miró JM; AERI study Group.

Enferm Infecc Microbiol Clin. 2011 Aug-Sep;29(7):482-9. doi: 10.1016/j.eimc.2011.03.001. Epub 2011 May 2.

PMID:
21543135
[PubMed - indexed for MEDLINE]
19.

Prevalence of drug resistance and importance of viral load measurements in Honduran HIV-infected patients failing antiretroviral treatment.

Murillo W, de Rivera IL, Parham L, Jovel E, Palou E, Karlsson AC, Albert J.

HIV Med. 2010 Feb;11(2):95-103. doi: 10.1111/j.1468-1293.2009.00747.x. Epub 2009 Aug 3.

PMID:
19686436
[PubMed - indexed for MEDLINE]
20.

Evidence of differential selection of HIV-1 variants carrying drug-resistant mutations in seroconverters.

Corvasce S, Violin M, Romano L, Razzolini F, Vicenti I, Galli A, Duca P, Caramma I, Balotta C, Zazzi M.

Antivir Ther. 2006;11(3):329-34.

PMID:
16759049
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk